We are live on
!
Find out more
PIS
POM Investment Strategies Portfolio holdings
AUM
$88.3M
1-Year Est. Return
15.23%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+15.23%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow
% of AUM
93.22%
Top 10 Holdings %
Top 10 Hldgs %
78.98%
Holding
231
New
230
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Top 50 ETF
XLG
|
+$10.7M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$10.6M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$10.6M |
| 4 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$10.5M |
| 5 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$10.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.75% |
| 2 | Healthcare | 1.09% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Industrials | 0.61% |
| 5 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $5.86K | 0.01% |
+43
| New | +$5.59K |
|
127
FLEX LNG
FLNG
$1.6B
| $5.81K | 0.01% |
+200
| New | +$6K |
|
128
Toyota
TM
$223B
| $5.32K | ﹤0.01% |
+29
| New | +$5.29K |
|
129
Thermo Fisher Scientific
TMO
$223B
| $5.31K | ﹤0.01% |
+10
| New | +$4.84K |
|
130
iShares MSCI Japan ETF
EWJ
$23.1B
| $5K | ﹤0.01% |
+78
| New | +$4.77K |
|
131
Magyar Bancorp
MGYR
$123M
| $4.8K | ﹤0.01% |
+428
| New | +$4.22K |
|
132
MINISO
MNSO
$3.55B
| $4.49K | ﹤0.01% |
+220
| New | +$5.27K |
|
133
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $4.42K | ﹤0.01% |
+38
| New | +$4.05K |
|
134
Aon
AON
$74.7B
| $4.37K | ﹤0.01% |
+15
| New | +$4.8K |
|
|
OTLY
135
Oatly Group
OTLY
$420M
| $4.25K | ﹤0.01% |
+180
| New | +$2.97K |
|
136
Cintas
CTAS
$81.4B
| $4.22K | ﹤0.01% |
+28
| New | +$3.75K |
|
137
Enbridge
ENB
$112B
| $4.07K | ﹤0.01% |
+113
| New | +$3.81K |
|
138
Realty Income
O
$59.2B
| $3.97K | ﹤0.01% |
+69
| New | +$3.62K |
|
139
BCE
BCE
$21.6B
| $3.94K | ﹤0.01% |
+100
| New | +$3.87K |
|
140
Progressive
PGR
$121B
| $3.66K | ﹤0.01% |
+23
| New | +$3.6K |
|
141
Novartis
NVS
$290B
| $3.63K | ﹤0.01% |
+36
| New | +$3.48K |
|
142
PayPal
PYPL
$50.6B
| $3.44K | ﹤0.01% |
+56
| New | +$3.21K |
|
143
Illinois Tool Works
ITW
$83.3B
| $3.4K | ﹤0.01% |
+13
| New | +$3.12K |
|
144
Vertex Pharmaceuticals
VRTX
$133B
| $3.25K | ﹤0.01% |
+8
| New | +$2.96K |
|
145
UnitedHealth
UNH
$364B
| $3.16K | ﹤0.01% |
+6
| New | +$3.2K |
|
146
Zoetis
ZTS
$30.4B
| $3.16K | ﹤0.01% |
+16
| New | +$2.83K |
|
147
JPMorgan Equity Premium Income ETF
JEPI
$46.1B
| $3.08K | ﹤0.01% |
+56
| New | +$3.02K |
|
148
LXP Industrial Trust
LXP
$3.58B
| $3.03K | ﹤0.01% |
+61
| New | +$2.66K |
|
149
Canadian National Railway
CNI
$76.4B
| $3.02K | ﹤0.01% |
+24
| New | +$2.72K |
|
150
TJX Companies
TJX
$169B
| $3K | ﹤0.01% |
+32
| New | +$2.87K |
|
Similar funds
MPEM
RFL
PBCM
BCP
CVM
DG
HI
SCA
POM Investment Strategies's Q4 2023 Portfolio in Review
Q4 2023 is the first quarter with a 13F filing on record for POM Investment Strategies, which disclosed 231 positions worth $109M. Its ten largest holdings account for 79% of the portfolio.
Its largest position is Invesco S&P 500 Top 50 ETF: 300,892 shares worth $11.3M.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, followed by Healthcare and Consumer Discretionary.
- POM Investment Strategies's largest Q4 2023 buy was Invesco S&P 500 Top 50 ETF: 300,892 shares worth $11.3M.
- POM Investment Strategies's ten largest holdings make up 79% of its $109M portfolio in Q4 2023.
- POM Investment Strategies disclosed 231 positions in Q4 2023, its first 13F filing on record.
Based on POM Investment Strategies's 13F filing for Q4 2023, filed 15 May 2024.